• SOMAVAC®  Named One of “Five Companies to Watch” from LSI Market Insights

    At the core of LSI’s Emerging Medtech Summits are our innovators. This year, 362 early and growth-stage companies took the stage to share how their technologies aim to improve outcomes and extend lives. With so many impressive presentations, our Market Intelligence analyst team selected five standout companies to highlight, each bringing differentiated technology, validated market…

  • LSI: SOMAVAC® Redefining Post-Surgical Recovery for Breast Cancer Patients

    Under the direction of CEO Elizabeth Hoff, SOMAVAC is challenging the status quo of post-surgical care with its innovative negative pressure solutions. By improving the patient experience and reducing complications associated with seromas, SOMAVAC addresses “the most ignored known problem in mastectomy and breast reconstruction: the outdated and often distressing process of managing surgical drains,…

  • SOMAVAC® Selected to Present at TLSF 2024

    SOMAVAC® presenting at the 13th Annual Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is Texas’ premier life science and health-tech event, taking place on November 7, 2024 to unite industry professionals, investors, and executives.

  • SOMAVAC® Receives Strong Reception at ASPS Annual Meeting

    There was strong recognition at ASPS that seroma mitigation and elimination are essential to transforming outcomes for breast reconstruction patients. Attendees were particularly excited by SOMAVAC’s FDA-cleared technology.

  • SOMAVAC® CEO Elizabeth Hoff Presents at LSI Europe: Technology Receives Enthusiastic Response

    Elizabeth Hoff’s presentation focused on SOMAVAC’s negative pressure wound therapy device, which is designed to address the unmet needs of patients recovering from large flap surgeries, including breast cancer reconstructions.

  • SOMAVAC® Welcomes Dr. Aldona Spiegel as New Strategic Advisor

    We are honored to have Dr. Spiegel on board and look forward to her guidance as we continue to push the boundaries of patient care and innovation. Dr. Spiegel’s passion for advancing medical technology aligns perfectly with SOMAVAC’s commitment to transforming the post-operative recovery process.

  • Brief conversation with Phil Ryan (COO, SOMAVAC® Medical)

    The transcript features a conversation between Abigail and Phil Ryan, who is the Chief Operating Officer at Silverback, a company he joined in 2019 after working at a large medical device manufacturer. Phil discusses his transition from a large company to a smaller, nimble organization like Silverback. He outlines the roles he has taken on,…

  • SOMAVAC® Medical Granted US Patent (11,078,898)

    The SOMAVAC® SVS is the ONLY smart surgical drain pump cleared by the FDA to prevent seromas in plastic and general surgery. Most commonly used for mastectomies, breast reconstructions, hernia repairs, tummy tucks and complex orthopedic procedures.

  • Welcoming Keith Gordon, RN as a Senior Clinical Support Team Member

    Keith Gordon discussed his positive transition and busy schedule at Silverback as a new clinical specialist, highlighting his enthusiasm for being on the road, interacting with doctors and patients, and introducing new technology. He expressed excitement about the S-VHS device, praising its benefits for hospital efficiency and patient convenience, especially in comparison to traditional JP…

  • ‘Smart’ pump latest medical device created in Memphis

    The article discusses the innovations made by SOMAVAC in surgical drain technology, led by CEO Esra Roan. SOMAVAC has developed a device that automates the draining and collection of surgical fluids, improving upon the traditional Jackson-Pratt bulb, which has been the standard for decades. This technology offers advantages like continuous negative pressure, which reduces complications…